XERS
Xeris Pharmaceuticals Inc
Price:  
4.75 
USD
Volume:  
1,081,665.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

XERS EV/EBITDA

-118.6%
Upside

As of 2025-07-06, the EV/EBITDA ratio of Xeris Pharmaceuticals Inc (XERS) is 442.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XERS's latest enterprise value is 932.08 mil USD. XERS's TTM EBITDA according to its financial statements is 2.11 mil USD. Dividing these 2 quantities gives us the above XERS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative Enterprise Value.

Range Selected
Trailing P/E multiples 8.2x - 13.0x 10.7x
Forward P/E multiples 15.3x - 18.5x 17.8x
Fair Price (0.96) - (0.83) (0.88)
Upside -120.2% - -117.4% -118.6%
4.75 USD
Stock Price
(0.88) USD
Fair Price

XERS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-20 424.13
2025-06-18 429.45
2025-06-17 426.41
2025-06-16 415.77
2025-06-13 411.97
2025-06-12 417.29
2025-06-11 414.25
2025-06-10 427.17
2025-06-09 421.85
2025-06-06 429.45
2025-06-05 420.33
2025-06-04 418.05
2025-06-03 434.77
2025-06-02 465.18
2025-05-30 456.82
2025-05-29 464.42
2025-05-28 444.66
2025-05-27 448.46
2025-05-23 448.46
2025-05-22 452.26
2025-05-21 455.30
2025-05-20 467.46
2025-05-19 451.50
2025-05-16 452.26
2025-05-15 445.42
2025-05-14 434.01
2025-05-13 453.78
2025-05-12 457.58
2025-05-09 462.14
2025-05-08 473.54
2025-05-07 421.85
2025-05-06 408.17
2025-05-05 434.01
2025-05-02 439.33
2025-05-01 421.85
2025-04-30 428.69
2025-04-29 416.53
2025-04-28 416.53
2025-04-25 408.93
2025-04-24 406.65
2025-04-23 395.25
2025-04-22 392.97
2025-04-21 386.89
2025-04-17 393.73
2025-04-16 391.45
2025-04-15 414.25
2025-04-14 397.53
2025-04-11 397.53
2025-04-10 381.56
2025-04-09 410.45